Downregulation of CAV1 reduces the levels of GPX4 and FTH1, increases ROS and Fe2+ concentrations, promotes ferroptosis, and reduces cancer cell migration and invasion,171 suggesting that the regulatory pathways of CAV1 and ferroptosis may be potential targets for diagnosis and combination therapy strategies in patients with HNSCC. This evidence concerns the gene CAV1 and cancer.